Thus, the first aim was to test whether obese individuals with T2DM have CHRNA7 downregulation and CHRFAM7A and TNF-α upregulation expression in leukocytes when compared to healthy individuals without T2DM. This evidence concerns the gene CHRFAM7A and type 2 diabetes mellitus.